Tag: Information

  • Medical Product Alert N° 1/2020 (English version)

    Medical Product Alert N° 1/2020 (English version)

     

    Falsified antimalarials in West and Central Africa displaying an outdated WHO Essential Drugs Programme logo

    This Medical Product Alert relates to a series of confirmed falsified antimalarials circulating in West and Central Africa. Medicines subject of this alert display a similar logo to the outdated
    WHO Essential Drugs Programme logo.
     

    Since 2013, different falsified medicines, all displaying the outdated WHO Essential Drugs Programme logo, have been reported to the WHO Global Surveillance and Monitoring System by various stakeholders. The continued and widespread availability of these falsified medicines highlights a strong need for additional vigilance. WHO previously published two alerts on this issue (No.132 in Oct 2014, and No.131 in March 2014)

    This WHO medical product alert N°1/2020 refers to falsified Quinine Sulphate 300mg presented in six different combinations of batch numbers, expiry and manufacturing dates (see Table 1). The fraudulent use of the outdated WHO Essential Drugs Programme logo may create a false sense of product quality.

    Table 1: List of identified falsified Quinine Sulphate 300mg, subject of WHO Alert N°1/2020

    Medical Product Alert N° 1/2020 (English version) 1

    Recently received results of analysed samples show they do not contain any of the expected active ingredients.

    Quinine sulphate is referenced on the WHO Model List of Essential Medicines, to manage and treat severe malaria. At this stage, no adverse reactions attributed to these falsified products have been reported to WHO.    

    All the above falsified products claim to be manufactured by REMEDICA LTD – Cyprus and to contain 300mg of quinine sulphate. Remedica Ltd has confirmed that:

    • they did not manufacture the above falsified products; and
    • the variable data (batch number and dates) on the above products has never been used by Remedica.

     These falsified medicines display the following common characteristics (please see photographs):

    • grey or white plastic containers which contain 1000 loose circular tablets each;
    • display the outdated WHO Essential Drugs Programme logo;
    • English and French labelling with mistakes and inconsistencies; and
    • discovered at patient level in both regulated and unregulated outlets.

    Product details, photographs and advice to the public are available on the following pages.

    Outdated WHO Essential Drugs Programme logo 

    Medical Product Alert N° 1/2020 (English version) 2

    Photographs of confirmed falsified Quinine Sulphate 300mg tablets subject of
    Medical Product Alert N°1/2020

    1.       Falsified
    Quinine Sulphate Tablets B.P 300mg
    identified
    in Chad (Batch 44680)

    Medical Product Alert N° 1/2020 (English version) 3

     

    Medical Product Alert N° 1/2020 (English version) 4

    Medical Product Alert N° 1/2020 (English version) 5Medical Product Alert N° 1/2020 (English version) 6Medical Product Alert N° 1/2020 (English version) 7

    Medical Product Alert N° 1/2020 (English version) 8

     

    WHO requests increased vigilance within the supply chains of countries likely to be affected by these falsified products. Increased vigilance should include hospitals, clinics, health centres, wholesalers, distributors, pharmacies and any other suppliers of medical products.

    If you are in possession of the above products, please do not use. If you have used these falsified products, or if you suffer an adverse event having used these products, please seek immediate advice from a qualified healthcare professional, and ensure they report the incident to your local Ministry of Health/National Medicines Regulatory Authorities/National Pharmacovigilance Centre.

    All medical products must be obtained from authentic and reliable sources. Their authenticity and condition should be carefully checked. Seek advice from a healthcare professional in case of doubt.

    National health authorities are asked to immediately notify WHO if these falsified products are discovered in their country. If you have any information concerning the manufacture, distribution, or supply of these products, please contact rapidalert@who.int . 

    WHO Global Surveillance and Monitoring System

    for Substandard and Falsified Medical Products

    For further information, please visit our website: www.who.int/medicines/regulation/ssffc/en/

     

    Medical Product Alert N° 1/2020 (English version)
    Read More
    https://www.who.int/news-room/detail/09-03-2020-medical-product-alert-n-1-2020-english-version

    Views: 0

  • A scheme for hybrid access point (H-AP) deployment in smart cities

    A scheme for hybrid access point (H-AP) deployment in smart cities

    Researchers at the University of Essex, UESTC-China and ZTE have recently introduced a scheme for the deployment of hybrid access points (H-APs), which could simultaneously enable wireless information transfer (WIT) and wireless energy transfer (WET) in smart cities. This unique scheme, presented in a paper pre-published on arXiv, uses a mobility model of grid-based streets in urban environments to represent the movements of users navigating a city.

    Read More

    Views: 0

  • WHO statement on cases of COVID-19 surpassing 100 000

    WHO statement on cases of COVID-19 surpassing 100 000

    As of today’s reports, the global number of confirmed cases of COVID-19 has surpassed 100 000. As we mark this sombre moment, the World Health Organization (WHO) reminds all countries and communities that the spread of this virus can be significantly slowed or even reversed through the implementation of robust containment and control activities. 

    China and other countries are demonstrating that spread of the virus can be slowed and impact reduced through the use of universally applicable actions, such as working across society to identify people who are sick, bringing them to care, following up on contacts, preparing hospitals and clinics to manage a surge in patients, and training health workers.

    WHO calls on all countries to continue efforts that have been effective in limiting the number of cases and slowing the spread of the virus. 

    Every effort to contain the virus and slow the spread saves lives. These efforts give health systems and all of society much needed time to prepare, and researchers more time to identify effective treatments and develop vaccines. 

    Allowing uncontrolled spread should not be a choice of any government, as it will harm not only the citizens of that country but affect other countries as well. 

    We must stop, contain, control, delay and reduce the impact of this virus at every opportunity. Every person has the capacity to contribute, to protect themselves, to protect others, whether in the home, the community, the health care system, the work place or the transport system. 

    Leaders at all levels and in all walks of life must step forward to bring about this commitment across society. 

    WHO will continue to work with all countries, our partners and expert networks to coordinate the international response, develop guidance, distribute supplies, share knowledge and provide people with the information they need to protect themselves and others.

    WHO statement on cases of COVID-19 surpassing 100 000
    Read More
    https://www.who.int/news-room/detail/07-03-2020-who-statement-on-cases-of-covid-19-surpassing-100-000

    Views: 0

  • Congress blasts Boeing missteps, FAA blunders on MAX, calls for reform

    Congress blasts Boeing missteps, FAA blunders on MAX, calls for reform

    Boeing made missteps and withheld information about the 737 MAX while federal regulators failed to provide proper oversight, leading to a “fundamentally flawed” aircraft that demands tighter rules, a US congressional committee said Friday.

    Read More

    Views: 0

  • Super Tuesday marks first major security test of 2020

    Super Tuesday marks first major security test of 2020

    Tuesday’s presidential primaries across 14 states mark the first major security test since the 2018 midterm elections, with state and local election officials saying they are prepared to deal with everything from equipment problems to false information about the coronavirus.

    Read More

    Views: 0

  • Even after blocking an ex on Facebook, the platform promotes painful reminders

    Even after blocking an ex on Facebook, the platform promotes painful reminders

    Anthony Pinter, a Ph.D. student in information science at the University of Colorado Boulder, recently completed a study on people’s experiences with upsetting and unexpected reminders of an ex on Facebook.

    Read More

    Views: 0

  • Coder charged in massive CIA leak portrayed as vindictive

    Coder charged in massive CIA leak portrayed as vindictive

    A software engineer on trial for the largest leak of classified information in CIA history was “prepared to do anything” to betray the agency, federal prosecutors said Monday as a defense attorney argued the man had been scapegoated for a breach that exposed secret cyberweapons and spying techniques.

    Read More

    Views: 0

  • Coronavirus: How Twitter could more effectively ease its impact

    Coronavirus: How Twitter could more effectively ease its impact

    In the wake of a disaster or crisis, people turn to trusted sources for information.

    Read More

    Views: 0

  • Facebook sues analytics firm for data misuse

    Facebook sues analytics firm for data misuse

    Facebook on Thursday filed a federal lawsuit against oneAudience data intelligence firm over a tactic it used to gather information about users of social media platforms.

    Read More

    Views: 1